GERN
USDGeron Corporation Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$1.200
Máximo
$1.220
Mínimo
$1.140
Volume
8.19M
Fundamentos da empresa
Capitalização de mercado
733.7M
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
7.83M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Geron Corporation to Present at Upcoming Investor Conferences
Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Harout Semerjian, Chief Executive Officer, is scheduled
Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies
New analysis from the Phase 3 IMerge clinical trial, accepted as an oral presentation, explores relationship between treatment-emergent cytopenias and clinical response in LR-MDS Additional poster presentations
Ações relacionadas
FTAIP
FTAI Aviation Ltd. 8.25% Fixed to Floating Rate Series A Cumulative Perpetual Redeemable Preferred Shares
CHSCM
CHS Inc Reset Rate Cumulative Redeemable Preferred Stock Series 3
MRBK
Meridian Corporation
ATEX
Anterix Inc.
CPAY
Corpay Inc.
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.